Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 6/20 | 0.61 |
| ▸ | CTSS | P25774 | 3/20 | 0.61 |
| ▸ | CTSK | P43235 | 3/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.59 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.59 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.59 |
| ▸ | PRKACA | P17612 | 1/20 | 0.59 |
| ▸ | GSK3A | P49840 | 1/20 | 0.59 |
| ▸ | GSK3B | P49841 | 1/20 | 0.59 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.59 |
| ▸ | PRKX | P51817 | 1/20 | 0.59 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.59 |
| ▸ | PRKG1 | Q13976 | 1/20 | 0.59 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.59 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.59 |
| ▸ | SGK2 | Q9HBY8 | 1/20 | 0.59 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.58 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4364556 | 0.94 | CTSL (0.63) | CTSLCTSSCTSKMAPK1CYP3A4 | |
| SCHEMBL24368194 | 0.92 | NPC1 (0.62) | CTSLCTSSCTSKMAPK1CYP3A4 | |
| SCHEMBL13669585 | 0.92 | NPC1 (0.54) | CTSLCTSSCTSKMAPK1CYP3A4 | |
| SCHEMBL24368211 | 0.92 | NPC1 (0.62) | CTSLCTSSCTSKMAPK1CYP3A4 | |
| SCHEMBL4367288 | 0.92 | CTSL (0.58) | CTSLCTSSCTSKMAPK1CYP3A4 | |
| SCHEMBL4361619 | 0.91 | CTSL (0.56) | CTSLCTSSCTSKMAPK1CYP3A4 | |
| SCHEMBL27679119 | 0.91 | CTSL (0.56) | CTSLCTSSCTSKMAPK1CYP3A4 | |
| SCHEMBL24368193 | 0.91 | NPC1 (0.60) | CTSLCTSSCTSKMAPK1CYP3A4 | |
| SCHEMBL4360827 | 0.91 | MAPK1 (0.58) | CTSLCTSSCTSKMAPK1CYP3A4 | |
| SCHEMBL24368209 | 0.91 | NPC1 (0.67) | CTSLCTSSCTSKMAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4436951-B1 | USE OF AURANTIAMIDE ACETATE IN THE TREATMENT OF HYPERTENSION | AKDENIZ UNIV SERMAYE ISLETME MUDURLUGU (TR) | 2026-04-08 | — | — | EP | claimed |
| CN-120053595-A | Use of compounds for the treatment of hair loss | 澳门科技大学 | 2025-05-30 | — | — | CN | claimed |
| EP-4229639-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS Global Biopharma, Inc. (CA) | 2023-08-23 | — | — | EP | claimed |
| CN-115010618-B | Separation and purification method of aureoyl amide alcohol ester capable of reducing uric acid and application thereof | 江西省科学院应用化学研究所 | 2022-11-01 | — | — | CN | claimed |
| CN-115010618-A | Separation and purification method of aureoyl amide alcohol ester capable of reducing uric acid and application thereof | 江西省科学院应用化学研究所 | 2022-09-06 | — | — | CN | claimed |
| CN-114588145-A | Application of amide alkaloid in preparation of alpha-glucosidase inhibiting drugs | 复旦大学 | 2022-06-07 | — | — | CN | claimed |
| WO-2022081889-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS GLOBAL BIOPHARMA, INC. (CA) | 2022-04-21 | — | — | WO | claimed |
| US-20090247470-A1 | PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF | The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) | 2009-10-01 | — | — | US | claimed |
| EP-4436951-B1 | USE OF AURANTIAMIDE ACETATE IN THE TREATMENT OF HYPERTENSION | AKDENIZ UNIV SERMAYE ISLETME MUDURLUGU (TR) | 2026-04-08 | — | — | EP | disclosed |
| EP-4436951-B1 | USE OF AURANTIAMIDE ACETATE IN THE TREATMENT OF HYPERTENSION | AKDENIZ UNIV SERMAYE ISLETME MUDURLUGU (TR) | 2026-04-08 | — | — | EP | disclosed |
| CN-120053595-A | Use of compounds for the treatment of hair loss | 澳门科技大学 | 2025-05-30 | — | — | CN | disclosed |
| CN-119633029-A | Application of plant extract of herba Violae Alternifoliae in preparing medicine for preventing and treating diabetic retinopathy | 河北大学 | 2025-03-18 | — | — | CN | disclosed |
| EP-4436951-A4 | USE OF AURANTIAMIDE ACETATE IN THE TREATMENT OF HYPERTENSION | Akdeniz Universitesidoner Sermaye Isletme Mudurlugu (TR) | 2025-03-12 | — | — | EP | disclosed |
| CN-119235884-A | Application of virtual screening compound in preparation of farnesol X receptor agonist and medicine | 桂林医学院 | 2025-01-03 | — | — | CN | disclosed |
| WO-2022081889-A1 | METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE | GBS GLOBAL BIOPHARMA, INC. (CA) | 2022-04-21 | — | — | WO | disclosed |
| CN-112500308-A | Golden acylamide alcohol ester and fluorinated derivative thereof, preparation method and application | 澳门科技大学 | 2021-03-16 | — | — | CN | disclosed |
| US-9023809-B2 | Phenylalanine dipeptide derivatives, compositions and use thereof | THE KEY LABORATORY OF CHEMISTRY FOR NATURAL PRODUCTS OF GUIZHOU PROVINCE AND CHINESE ACADEMY OF SCIENCES (CN) | 2015-05-05 | — | — | US | disclosed |
| US-20090247470-A1 | PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF | The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) | 2009-10-01 | — | — | US | disclosed |
| CN-1194676-C | Use of amfetamine alcohol compounds as medicine for treating hepatitis B and preparation method thereof | NATURAL PRODUCTS CHEMICAL KEY (CN) | 2005-03-30 | — | — | CN | disclosed |
| CN-1437937-A | Use of amfetamine alcohol compounds as medicine for treating hepatitis B and preparation method thereof | NATURAL PRODUCTS CHEMICAL KEY (CN) | 2003-08-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247470-A1 | PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF | DNPEP, PEPD, VIP | CTSL 591/4885CTSS 3153/4885CTSK 2637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.